Next Generation Sequencing Market - Global Forecast 2026-2032

The Next Generation Sequencing Market is projected to reach USD 14.75 Billion in 2026. It is expected to continue growing at a CAGR of 16.72%, reaching USD 37.48 Billion by 2032.

Next generation sequencing has moved from a specialized research workflow into a core infrastructure layer for precision medicine, oncology, inherited disease testing, infectious disease surveillance, reproductive health, pharmacogenomics, agriculture, and biomanufacturing. The market is supported by verified advances in sequencing chemistry, library preparation, laboratory automation, and cloud-based bioinformatics that have reduced turnaround time while increasing throughput, scalability, and read accuracy.

Demand is strongest where NGS links directly to clinical utility, reimbursement readiness, drug development productivity, and public health value. Cancer profiling, rare disease diagnosis, liquid biopsy research, pathogen genomics, newborn screening research, and population-scale sequencing programs continue to expand adoption as laboratories seek scalable platforms that combine reliable data generation with validated interpretation and secure data management.

Transformative Shifts Reshaping Next Generation Sequencing

The NGS landscape is being reshaped by three structural shifts: the move from short-read dominance to a mixed short-read and long-read ecosystem, the migration of analysis from local servers to secure cloud and hybrid environments, and the integration of sequencing into routine clinical decision-making. High-throughput instruments now support population-scale projects, while benchtop and mid-throughput systems enable decentralized testing in hospital, regional, and specialty laboratories.

Long-read sequencing is gaining adoption for structural variants, repeat expansions, haplotype phasing, genome assembly, and metagenomics, while short-read platforms remain essential for cost-efficient oncology panels, exomes, transcriptomes, and high-volume sample processing. At the same time, regulatory-grade software, laboratory automation, sample-to-report workflows, interoperability, and quality management are becoming competitive differentiators as buyers prioritize reproducibility, compliance, and operational efficiency.

Cumulative Impact of Artificial Intelligence in NGS

Artificial intelligence is compounding the value of NGS by improving base calling, variant prioritization, annotation, quality control, and clinical interpretation. AI-enabled tools help reduce manual curation burden, identify sequencing artifacts, detect complex patterns in genomic and transcriptomic data, and accelerate the interpretation of large-scale genomic, epigenomic, and multiomic datasets.

The most significant impact is cumulative: each additional validated dataset can improve model performance, while each automated workflow can reduce turnaround time and cost per insight. In clinical environments, AI is particularly valuable for triaging variants of uncertain significance, linking genomic findings to phenotype data, supporting molecular tumor boards, and strengthening decision support. Governance remains critical, as algorithms must be validated, auditable, explainable where required, and aligned with privacy, cybersecurity, and medical-device requirements.

Key Regional Insights

North America remains a leading NGS region because of strong academic medical centers, advanced reference laboratory networks, biomedical funding, clinical trial activity, and broad adoption of oncology, rare disease, pharmacogenomics, and infectious disease sequencing. Europe benefits from national genomics strategies, mature biobank assets, cancer and rare disease programs, and regulation-led emphasis on data protection and clinical quality, with health-data initiatives expected to improve responsible cross-border data use over time.

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and ASEAN economies invest in precision medicine, reproductive genomics, oncology testing, population genomics, and infectious disease surveillance. Latin America shows rising demand in Brazil and Mexico, supported by private diagnostics, academic collaborations, and expanding molecular laboratory capacity. The Middle East is advancing through national genome programs, preventive health strategies, and specialist hospital infrastructure, especially in Gulf countries, while Africa is building sequencing capacity through pathogen surveillance, human genomics initiatives, antimicrobial resistance monitoring, and regional research networks that improve genomic representation.

Key Group Insights

Among major economic and geopolitical groups, the G7 continues to lead in clinical adoption, reimbursement development, regulatory science, genomic medicine programs, and advanced sequencing infrastructure. The European Union is distinguished by coordinated health-data policy, genomics networks, rare disease collaboration, cancer mission priorities, and harmonized quality frameworks that support cross-country research and clinical implementation.

BRICS economies are increasingly important for high-volume sequencing demand, local manufacturing ambitions, biopharmaceutical research, and large-population genomic diversity. ASEAN markets are at varied stages, with Singapore and Thailand moving faster in clinical genomics and precision medicine adoption, while Indonesia, Vietnam, Malaysia, and the Philippines continue to expand laboratory capacity and workforce skills. GCC countries are investing in national genome initiatives, preventive medicine, population health, and specialized diagnostics, while NATO members benefit from strong biomedical research systems, biosecurity priorities, defense-related public health preparedness, and infectious disease surveillance capabilities.

Key Country Insights

The United States is a major NGS commercialization hub, supported by advanced diagnostics, biopharma demand, academic medicine, public health genomics, and large population research programs. Canada contributes through cancer genomics, newborn and rare disease initiatives, and publicly supported research networks, while Mexico and Brazil are strengthening private diagnostics, oncology testing access, and academic sequencing networks across Latin America.

In Europe, the United Kingdom, Germany, and France lead through national genomics programs, cancer strategies, rare disease frameworks, and industrial biotechnology capacity, while Italy and Spain are expanding hospital-based molecular testing and translational genomics. Russia maintains scientific capability in genomics and molecular biology but faces procurement, funding, and international collaboration constraints. In Asia-Pacific, China has substantial sequencing scale and population genomics activity, India is growing through affordability, disease diversity, and expanding diagnostic access, Japan and South Korea emphasize high-quality clinical adoption, oncology genomics, and advanced research infrastructure, and Australia supports genomics through public health programs, rare disease research, cancer genomics, and national research infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize workflows that deliver measurable clinical, operational, or research outcomes rather than competing only on sequencing cost. Commercial success increasingly depends on end-to-end solutions that integrate sample preparation, sequencing, bioinformatics, reporting, data security, interoperability, quality assurance, and regulatory documentation.

Executives should build partnerships with hospitals, reference laboratories, biopharmaceutical developers, public health agencies, and national genomics programs to secure high-value use cases. Investment should focus on automation, AI-assisted interpretation, reimbursement evidence, decentralized testing support, workforce training, data governance, and compliance with evolving privacy, cybersecurity, and diagnostic regulations. Organizations that combine platform performance with trusted data interpretation, validated clinical evidence, and regionally adapted deployment models will be best positioned for durable growth.

Research Methodology

This executive summary is developed using secondary research from verified public sources, including regulatory agencies, national genomics programs, public health organizations, peer-reviewed literature, clinical guideline bodies, reimbursement references, government health-data initiatives, and published scientific collaborations. Market interpretation emphasizes documented technology adoption, policy direction, clinical use cases, regulatory context, and infrastructure investment.

The analysis applies a triangulated approach that compares platform trends, regional healthcare capacity, reimbursement maturity, research funding, regulatory readiness, laboratory infrastructure, and end-user demand across clinical diagnostics, pharmaceutical research, public health, agriculture, and academic genomics. Insights are synthesized to identify structural drivers, constraints, and strategic priorities without relying on unverified claims, market sizing, market share estimates, or unsupported projections.

Conclusion

Next generation sequencing is becoming a foundational technology for data-driven healthcare and life sciences. The market is no longer defined only by sequencing speed or cost; it is increasingly defined by the ability to convert genomic data into reliable, actionable, secure, and compliant decisions across clinical, research, public health, and industrial applications.

Adoption will be strongest where platforms, software, clinical evidence, reimbursement pathways, quality systems, and data governance align. As AI, long-read sequencing, multiomics, spatial biology, and population genomics mature, industry leaders that deliver validated workflows and regionally adapted strategies will be positioned to capture the highest-value opportunities in the global NGS ecosystem.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Next Generation Sequencing Market, by Technology

7.1. Introduction
7.2. Amplicon Sequencing
7.3. Gene Panel Sequencing
7.4. RNA Sequencing
7.5. Targeted Sequencing
7.6. Whole Exome Sequencing (WES)
7.7. Whole Genome Sequencing (WGS)

8. Next Generation Sequencing Market, by Product Type

8.1. Introduction
8.2. Consumables Reagents
8.2.1. Enzymes
8.2.2. Kits
8.3. Instruments
8.3.1. Ancillary Instruments
8.3.2. Sequencers
8.4. Software
8.5. Services

9. Next Generation Sequencing Market, by Read Length

9.1. Introduction
9.2. Short-Read
9.3. Long-Read

10. Next Generation Sequencing Market, by End User

10.1. Introduction
10.2. Academic Research Institutes
10.3. Healthcare Diagnostic Laboratories
10.4. Pharmaceutical Biotechnology Companies

11. Next Generation Sequencing Market, by Application

11.1. Introduction
11.2. Agrigenomics
11.3. Epigenomics
11.4. Forensic Genomics
11.5. Neurogenomics
11.6. Oncology
11.7. Pharmacogenomics

12. Next Generation Sequencing Market, by Region

12.1. Europe
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Middle East
12.6. Africa

13. Next Generation Sequencing Market, by Group

13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC

14. Next Generation Sequencing Market, by Country

14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. India
14.6. United Kingdom
14.7. France
14.8. South Korea
14.9. Canada
14.10. Italy
14.11. Australia
14.12. Brazil
14.13. Spain
14.14. Russia
14.15. Mexico

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Illumina, Inc.
16.2. Thermo Fisher Scientific, Inc.
16.3. QIAGEN N.V.
16.4. BGI Genomics Co., Ltd.
16.5. Oxford Nanopore Technologies plc.
16.6. Agilent Technologies, Inc.
16.7. Bio-Rad Laboratories, Inc.
16.8. Takara Bio Inc.
16.9. Eurofins Genomics GmbH
16.10. Pacific Biosciences of California, Inc.
16.11. F. Hoffmann-La Roche Ltd
16.12. Novogene Co., Ltd.
16.13. MGI Tech Co., Ltd.
16.14. GenScript Biotech Corporation
16.15. 10x Genomics, Inc.
16.16. DNAnexus, Inc.
16.17. Element Biosciences, Inc.
16.18. Fabric Genomics, Inc.
16.19. Integrated DNA Technologies, Inc.
16.20. Macrogen, Inc.
16.21. PerkinElmer, Inc.
16.22. PierianDx, Inc.
16.23. SeqWell, Inc.
16.24. Singular Genomics Systems, Inc.
16.25. Strand Life Sciences Pvt. Ltd.
16.26. Ultima Genomics, Inc.

List of Figures

FIGURE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEXT GENERATION SEQUENCING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL NEXT GENERATION SEQUENCING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL GENE PANEL SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL GENE PANEL SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL GENE PANEL SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CONSUMABLES REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CONSUMABLES REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CONSUMABLES REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ANCILLARY INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ANCILLARY INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ANCILLARY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SEQUENCERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SEQUENCERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SEQUENCERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SHORT-READ MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SHORT-READ MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SHORT-READ MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL LONG-READ MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL LONG-READ MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL LONG-READ MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HEALTHCARE DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HEALTHCARE DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HEALTHCARE DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL AGRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AGRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AGRIGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL EPIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL EPIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL EPIGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL NEUROGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL NEUROGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL NEUROGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 86. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 87. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 88. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 89. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 90. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 91. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 124. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 126. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 127. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 128. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 129. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 130. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 135. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 136. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 137. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 138. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 139. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 144. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 145. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 146. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 147. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 159. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 160. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 161. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 162. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 163. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 165. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 169. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 170. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 171. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 175. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 177. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 178. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 179. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 182. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 183. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 184. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 186. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 187. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 191. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 192. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 193. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 194. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 195. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 196. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 199. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 202. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 203. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 204. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 206. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 208. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 210. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 211. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 212. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 215. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 216. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 217. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 218. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 219. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 220. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 222. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 232. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 233. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 234. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 235. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 236. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 237. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 238. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 241. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 242. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 243. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 244. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 247. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 248. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 250. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 251. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 252. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 256. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 257. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 258. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 259. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 260. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 263. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 264. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 265. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 266. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 267. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 268. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 270. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 272. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 273. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 274. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 275. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 276. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 278. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 280. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 281. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 282. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 283. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 284. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 288. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 289. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 290. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 291. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 292. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 294. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 296. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 297. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2017-2032 (USD MILLION)
TABLE 298. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 299. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2017-2032 (USD MILLION)
TABLE 300. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 302. GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 303. GLOBAL NEXT GENERATION SEQUENCING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

Illumina, Inc.
Thermo Fisher Scientific, Inc.
QIAGEN N.V.
BGI Genomics Co., Ltd.
Oxford Nanopore Technologies plc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Takara Bio Inc.
Eurofins Genomics GmbH
Pacific Biosciences of California, Inc.
F. Hoffmann-La Roche Ltd
Novogene Co., Ltd.
MGI Tech Co., Ltd.
GenScript Biotech Corporation
10x Genomics, Inc.
DNAnexus, Inc.
Element Biosciences, Inc.
Fabric Genomics, Inc.
Integrated DNA Technologies, Inc.
Macrogen, Inc.
PerkinElmer, Inc.
PierianDx, Inc.
SeqWell, Inc.
Singular Genomics Systems, Inc.
Strand Life Sciences Pvt. Ltd.
Ultima Genomics, Inc.

Table Information

Report Attribute	Details
No. of Pages	183
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 14.75 Billion
Forecasted Market Value ( USD ) by 2032	$ 37.48 Billion
Compound Annual Growth Rate	16.7%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts Reshaping Next Generation Sequencing

Cumulative Impact of Artificial Intelligence in NGS

Key Regional Insights

Key Group Insights

Key Country Insights

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Short-read Sequencing Market - Global Forecast 2026-2032

Next-Generation Sequencing Sample Preparation Market - Global Forecast 2026-2032

Short-Read Sequencing - Global Strategic Business Report

Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report

Next Generation Sequencing Market Size, Share, Trends and Forecast by Sequencing Type, Product Type, Technology, Application, End-User, and Region, 2026-2034